On July 14, 2016, the Centers for Medicare and Medicaid Services (CMS) published the proposed rule for the Hospital Outpatient Prospective Payment System (HOPPS) for 2017. CMS has proposed to cut the reimbursement rate for Axial DXA, CPT 77080 in the hospital setting from the current national average of $100.69 to $63.33. This reimbursement cut will… Read more »
The National Osteoporosis Foundation frequently publishes position statements for the benefit of educating healthcare professionals and the general public on a particular issue and/or concern related to preventing osteoporosis and/or promoting strong bones throughout the lifespan. As part of NOF’s Methods and Processes for Developing Position Statements, we welcome public input and comments to the… Read more »
Millions of Americans are missing out on a chance to avoid debilitating fractures from weakened bones, researchers say, because they are terrified of exceedingly rare side effects from drugs that can help them. Last month, the American Society for Bone and Mineral Research, the National Osteoporosis Foundation and the National Bone Health Alliance put out… Read more »
One our Corporate Advisory Roundtable members, Juvent, announced very positive results from the St. Jude Children’s Hospital Clinical Trial. An 11% increase in bone density was seen in childhood cancer survivors through their product, Juvent® Dynamic Motion Therapy Platform. The study was published in the Journal of the American Medical Association (JAMA) Oncology. To learn more,… Read more »
NOF is pleased to share interviews recorded by the Medicare Nation podcast, media partner for NOF’s annual conference, the Interdisciplinary Symposium on Osteoporosis, held May 12-15, 2016 in Miami, FL. Medicare Nation is a weekly podcast dedicated to bringing listeners everything they need to know about Medicare but are afraid to ask. They feature interviews… Read more »
The Nation’s leading scientific and medical bone health experts call for action on the dangers of not treating osteoporosis more aggressively. They are urging healthcare professionals to increase diagnosis and patients to be aware of this risk. Read statements released by leading organizations in the field in this PRNewswire article.
NOF Trustee Heidi Skolnik, MS, CDN, FACSM, submitted a letter to the editor at the New York Times regarding its April 1, 2016 article, “Exercise is the Not the Path to Strong Bones.” Ms. Skolnik pointed out the importance of exercise to overall health, including fracture prevention. To view the New York Times article here: http://www.nytimes.com/2016/04/02/health/exercise-is-not-the-path-to-strong-bones.html View the letter to… Read more »
In a joint effort with the Pharmaceutical Research and Manufacturers of America (PhRMA), NOF released a report on new, innovative therapies being developed for the treatment of osteoporosis. The report, Medicines in Development for Osteoporosis, examines the nationwide effects of the disease and explores how new medications can improve and save lives. Links to the… Read more »
The Wall Street Journal recently published an article detailing the benefits of bisphosphonates outweighing the risks for many patients. Text from the full article is included below. View the original article with graphics and visuals. More Support for Osteoporosis Drugs: The benefits of bisphosphonates outweigh the risks for many patients, according to new research and… Read more »
This article from the October issue of Dr. Oz Magazine includes strategies to help keep your bones strong and features quotes from NOF Clinical Director, Dr. Andrea Singer and Senior Director of Science Policy, Taylor Wallace, Ph.D. Read the full article.